AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003
Patient Information Leaflet last updated on the eMC: 22/01/2010
PIL Bricanyl Respules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/01/2010 and displayed until Current
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
Updated on 08/04/2009 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 21/10/2008 and displayed until 08/04/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 23/07/2004 and displayed until 21/10/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 04/09/2002 and displayed until 23/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 14/09/2000 and displayed until 04/09/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   terbutaline sulphate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk